Laura Panjwani
Articles
Tumor Treating Fields Improve Survival in Glioblastoma
November 22, 2016
Article
Optune, a noninvasive device that delivers tumor-treating fields to the brain, had been found to improve efficacy compared to chemotherapy and is well-tolerated by patients with glioblastoma multiforme (GBM).
Revisiting Current Cervical Cancer Screening Guidelines for HPV-Vaccinated Women
November 18, 2016
Article
Due to a dramatic reduction of risk for cervical cancer in women who have received the HBV vaccine, there may be a reduction of screening for those women.
Early Detection Vital as HCC Rates Rise Among Hepatitis B Patients
November 14, 2016
Article
The incidence of hepatocellular carcinoma (HCC) in patients with hepatitis B is still on the rise, making screening and surveillance in this population all the more important.
Many Women With Cervical Cancer Not Receiving Recommended Therapy
November 09, 2016
Article
Brachytherapy is one of three treatments considered standard of care for women with advanced cervical cancer, and it significantly increases the chance of survival. However, less than half of patients with this disease receive standard of care.
New Standard Myeloma Therapies Making a Big Difference for Patients
November 08, 2016
Article
Dr. Sundar Jagannath discusses the benefits in progression-free survival and quality of life from newly-approved therapies for patients with multiple myeloma.
In Low-Risk Breast Cancer, Less Treatment May Be Better
July 29, 2016
Article
The field of breast cancer has evolved from the days of defaulting to chemotherapy for every patient, yet much work remains to individualize treatment. Though more promising novel regimens have become available, an expert urges clinicians to carefully weigh whether a particular new agent will provide a significant enough benefit to offset its associated toxicities, cost, and the time and commitment by the patient it requires.
Patients Still Getting Aggressive End-of-Life Treatment Though Unlikely to Benefit
June 08, 2016
Article
An analysis of over 28,000 patients younger than 65 with incurable cancers found that approximately three-fourths of them received aggressive care within the last 30 days of life and one-third died in the hospital.
Breaks From Prostate Cancer Hormone Therapy May Improve Quality of Life
February 04, 2016
Article
Androgen-deprivation therapy, while an effective treatment for prostate cancer, can result in side effects and a reduced quality of life.
Rolapitant Alleviates CINV: Q & A with Dr. Marleen Meyers
September 24, 2015
Article
Rolapitant (Varubi), which was recently approved by the FDA, has been shown to significantly reduce delayed phase CINV when used in combination with other antiemetic agents.
Caffeinated Coffee May Stave Off Colon Cancer Recurrence
August 26, 2015
Article
For patients with stage III colon cancer, drinking four or more cups of coffee per day may reduce risk of recurrence by 42% and death by 34%.